Observational studyHuman vaccines & immunotherapeutics2018
Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.
Observational study in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 22 citations in OpenAlex.
- A review of childhood rotavirus vaccination policies and a presentation of vaccine coverage trends at national and regional level, Italy, 2016 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Review
- Article
- Article
- Health Technology Assessment of Vaccines in Italy: History and Review of Applications.Vaccines · 2024Article
- Article
- Attitudes and Beliefs towards Rotavirus Vaccination in a Sample of Italian Women: A Cross-Sectional Study.Vaccines · 2023Article
- Article
- Molecular Study of Adenovirus Genotypes 40 and 41 in Children with Acute Gastroenteritis.Infectious disorders drug targets · 2022Article
- The evolving epidemiology of acute gastroenteritis in hospitalized children in Italy.European journal of pediatrics · 2022Article
- Impact of rotavirus vaccine in reducing hospitalization rates in pediatric patients: a single center experience in Italy.Human vaccines & immunotherapeutics · 2021Article
- Fourteen years' clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy.Human vaccines & immunotherapeutics · 2021Article
- Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence.Human vaccines & immunotherapeutics · 2021Article
- Opinions and attitudes of Italian healthcare workers towards recommended but not compulsory rotavirus vaccination.Human vaccines & immunotherapeutics · 2021Article
- Article
- Group A rotavirus surveillance before vaccine introduction in Italy, September 2014 to August 2017.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019Article
- Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily.Acta bio-medica : Atenei Parmensis · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rotavirus is considered the main cause of severe gastroenteritis and nosocomial infections in Pediatric units, especially during late winter and early spring season in temperate region. In 2013 Sicilian Region, for the first time in Italy, introduced universal Rotavirus vaccination. This study aims to estimate health and economic impact on rotavirus Gastroenteritis (RVGE) among children aged 0-59 months in Sicily, after rotavirus vaccine introduction. We analyzed hospital discharge records including a diagnosis of RVGE occurred from 1
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.